Medical University of Vienna
🇦🇹Austria
- Country
- 🇦🇹Austria
- Ownership
- Private
- Established
- 1365-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.meduniwien.ac.at
Assessment of Tear Film Thickness by Optical Coherence Tomography in Healthy Subjects and Subjects With Dry Eye Disease
Phase 3
Withdrawn
- Conditions
- Dry Eye Syndrome
- Interventions
- Device: GENTEAL HA® Eye Drops (NOVARTIS, Switzerland)Other: Physiological Sodium Chloride solution (0,9%)
- First Posted Date
- 2012-12-20
- Last Posted Date
- 2014-11-14
- Lead Sponsor
- Medical University of Vienna
- Registration Number
- NCT01753596
- Locations
- 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
High-resolution Imaging of Corneal Lesions With Optical Coherence Tomography (OCT) - A Pilot Study
Not Applicable
Completed
- Conditions
- Corneal AbrasionsCorneal Infiltrates
- Interventions
- Device: Optical Coherence Tomography (OCT)Other: Slit lamp biomicroscopy
- First Posted Date
- 2012-12-20
- Last Posted Date
- 2020-02-20
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 4
- Registration Number
- NCT01753583
- Locations
- 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
Non-invasive Measurement of Retinal Blood Flow Based on Vessel Analysis and Fourier Domain Optical Coherence Tomography in Patients With Hypertensive Retinopathy
Not Applicable
- Conditions
- Hypertensive Retinopathy
- Interventions
- Device: Dynamic Vessel AnalyzerOther: FDOCTOther: Ocular perfusion pressure
- First Posted Date
- 2012-12-20
- Last Posted Date
- 2022-04-07
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 60
- Registration Number
- NCT01753648
- Locations
- 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
Infloran® for Prevention of Necrotizing Enterocolitis
Completed
- Conditions
- Necrotizing Enterocolitis
- First Posted Date
- 2012-12-18
- Last Posted Date
- 2015-04-22
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 463
- Registration Number
- NCT01751477
- Locations
- 🇦🇹
Medical University Vienna, Vienna, Austria
🇦🇹Wilheminenspital der Stadt Wien, Vienna, Austria
Assessment of Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Subjects While Wearing Contact Lenses and Before Insertion of Contact Lenses
Phase 1
Completed
- Conditions
- Dry Eye Syndrome
- Interventions
- Device: Chitosan-N-acetylcysteine eye drops (concentration of 0.1%)Other: Physiological saline solution
- First Posted Date
- 2012-12-11
- Last Posted Date
- 2012-12-11
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 48
- Registration Number
- NCT01747616
- Locations
- 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
Neurovascular Coupling in Subjects With Amblyopia
Not Applicable
- Conditions
- Amblyopia ex StrabismusAmblyopia ex Anisometropia
- Interventions
- Device: Dynamic Vessel AnalyzerOther: Laser Doppler VelocimetryDevice: 7-Tesla MRIOther: Pattern electroretinographyOther: Fourier domain optical coherence tomography
- First Posted Date
- 2012-12-11
- Last Posted Date
- 2022-04-07
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 60
- Registration Number
- NCT01746693
- Locations
- 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
Assessment of Retinal Vessel Diameters and Red Blood Velocities in Patients With BRVO and Healthy Subjects
Not Applicable
- Conditions
- Retinal Blood FlowBranch Retinal Vein OcclusionRetinal Oxygen Saturation
- Interventions
- Device: Dynamic Vessel AnalyzerOther: Bidirectional Fourier-Domain Optical Coherence Tomography (FDOCT)
- First Posted Date
- 2012-12-11
- Last Posted Date
- 2022-04-07
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 60
- Registration Number
- NCT01746615
- Locations
- 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
Effect of Topical Glaucoma Therapy on Tear Film Stability in Healthy Subjects
Phase 3
Terminated
- Conditions
- Healthy
- Interventions
- Device: Hylo-Comod®Device: Genteal HA®Drug: Timoptic® 0.5%Drug: Timophtal sine® 0.5%Device: Thealoz®
- First Posted Date
- 2012-12-11
- Last Posted Date
- 2016-12-02
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 38
- Registration Number
- NCT01746602
- Locations
- 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
Reproducibility of Tearfilm Osmolarity Measurements Using TearLab® in Patients With Dry Eye Syndrome and Healthy Subjects
Not Applicable
Completed
- Conditions
- Dry Eye Syndrome
- Interventions
- Device: Measurement of tear film osmolarity with the TearLab® instrumentOther: Schirmer I testOther: Tear break up timeDevice: Optical Quality Analysis SystemOther: Ocular Surface Disease Index
- First Posted Date
- 2012-12-06
- Last Posted Date
- 2012-12-06
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 40
- Registration Number
- NCT01744457
- Locations
- 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
Posterior Capsule Opacification and Frequency of Nd:YAG Treatment and of Two Microincision IOLs: Tecnis ZCB00 and Acrysof SA60AT
Not Applicable
Completed
- Conditions
- Capsule OpacificationPseudophakiaCataract
- Interventions
- Procedure: intraocular lens implantation
- First Posted Date
- 2012-12-06
- Last Posted Date
- 2012-12-06
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 54
- Registration Number
- NCT01742910
- Locations
- 🇦🇹
Medical University Vienna, Vienna, Austria
© Copyright 2025. All Rights Reserved by MedPath